Cell line name |
ClearCa-19 |
Synonyms |
clearCa-19 |
Accession |
CVCL_X558 |
Resource Identification Initiative |
To cite this cell line use: ClearCa-19 (RRID:CVCL_X558) |
Sequence variations |
|
Disease |
Clear cell renal cell carcinoma (NCIt: C4033) Clear cell renal carcinoma (ORDO: Orphanet_319276) |
Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
Sex of cell |
Male |
Age at sampling |
39Y |
Category |
Cancer cell line |
Publications | PubMed=10737390; DOI=10.1054/bjoc.1999.1043; PMCID=PMC2374431 Engers R., Mrzyk S., Springer E., Fabbro D., Weissgerber G., Gerharz C.-D., Gabbert H.E. Protein kinase C in human renal cell carcinomas: role in invasion and differential isoenzyme expression. Br. J. Cancer 82:1063-1069(2000) CLPUB00411 Petek O. Analysis of expression and mutation of the antimetastatic gene NM23 in human renal carcinoma cell lines and epithelioid sarcomas. Thesis MD (2002); Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany CLPUB00407 Krieg A. Characterization and functional analysis of the TRAIL system and the inhibitor of apoptosis protein (IAP) family in human neoplasia. Thesis MD (2005); Heinrich-Heine-Universitat Dusseldorf; Dusseldorf; Germany PubMed=15863265; DOI=10.1016/j.canlet.2004.09.045 Reinecke P., Kalinski T., Mahotka C., Schmitz M., Dejosez M., Gabbert H.E., Gerharz C.-D. Paclitaxel/taxol sensitivity in human renal cell carcinoma is not determined by the p53 status. Cancer Lett. 222:165-171(2005) |
Cross-references |
Encyclopedic resources |
Wikidata; Q54813603
|
Polymorphism and mutation databases |
IARC_TP53; 23216
|
Entry history |
Entry creation | 05-Sep-2014 |
Last entry update | 19-Dec-2024 |
Version number | 10 |
---|